The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on September 2 under the chairmanship of Jean-Luc Belingard to approve the consolidated financial statements for the six months ended June 30, 2014. The Statutory Auditors had performed a limited review of the financial statements.
21 August, 2014
Combined capabilities will enhance the accuracy and range of microbial identification for pharmaceutical, food, veterinary labs.
AOAC Research Institute validates performance of automated food safety solution
Molecular test will quickly identify infectious causes of meningitis and encephalitis.
Solid growth in first-half sales
Expansion to help address the global public health threat of sepsis and meet the related demand for microbial detection.
In 2013, bioMérieux celebrated both its 50th anniversary and a remarkable entrepreneurial adventure at the service of public health worldwide.
bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce the appointment of Stefan Willemsen as President and CEO of bioMérieux Inc.
The General Meeting of Shareholders of bioMérieux, a world leader in the field of in vitro diagnostics, today approved the appointment of two new independent directors, Agnès Lemarchand and Philippe Gillet.
Amid the growing global threat from antibiotic resistant organisms, bioMérieux is leveraging its robust history of fighting infectious diseases to provide solutions and services that aid Antibiotic Stewardship Programs.
